Search results
Tiziana eyes orphan drug designation for multiple sclerosis treatment
Proactive Investors· 9 hours agoTiziana Life Sciences Ltd (NASDAQ:TLSA) has requested its multiple sclerosis treatment be granted...
This Mother's Day, I'm celebrating the fact that I can bake with my kid again. Not long ago, that...
INSIDER via Yahoo News· 17 hours agoReceiving treatment for multiple sclerosis allowed Lindsay Karp (not pictured) to start baking with...
9 celebrities with multiple sclerosis who have opened up about the disease
Yahoo Canada Style· 3 days ago“I knew nothing about the disease, to be honest. I fortunately had a doctor who told me right away...
Where will you be able to buy medical cannabis in 2025? See KY’s 11 dispensary regions
Lexington Herald-Leader via Yahoo News· 2 hours agoThe written certification...
Diagnosing Multiple Sclerosis: 5 Things to Know
Medscape· 4 days agoIn the United States, nearly 1 million people are living with multiple sclerosis (MS), an immune-mediated inflammatory disease that causes demyelination...
Sanofi boosts French biomanufacturing with €1 billion investment
Investing.com· 12 hours agoSanofi (EPA: SASY ) (NASDAQ: SNY ), a global biopharmaceutical company, announced today a...
3 Speculative Penny Stocks Offering High-Upside Potential for Under a Buck
InvestorPlace· 5 days agoThere are speculative ideas and then there are penny stocks under $1. If you’re still okay with the...
The CDC issues a report about infections from stem-cell treatments in Mexico
Associated Press· 4 days agoThe U.S. Centers for Disease Control and Prevention issued a report Thursday about three cases of...
Immunic advances ‘potentially groundbreaking’ MS therapy vidofludimus calcium during Q1
Proactive Investors· 5 days agoImmunic Inc (NASDAQ:IMUX) continued to advance its clinical programs for its lead drug asset,...
Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug
BioPharma Dive via Yahoo Finance· 5 hours agoThe deal gives the pharma partial rights to a medicine GSK once developed for heart disease but...